ITOCHU : to Invest in Regenerative Medicine Company Organ Technologies Inc.
June 20, 2018 at 12:13 am EDT
Share
ITOCHU Corporation ('ITOCHU', Head office: Minato-ku, Tokyo, President and COO: Yoshihisa Suzuki), Mitsui & Co., Ltd. ('Mitsui', Head office: Chiyoda-ku, Tokyo, President and CEO: Tatsuo Yasunaga),and Iyogin Capital Company Limited. ('IC company', Head office: Matsuyama-city, Ehime, Representative Director: Kenichi Oizumi) have invested approximately 590million to subscribe to a third-party allotment of new shares by Organ Technologies Inc. ('OT company', Head office: Minato-ku, Tokyo, President: Yasuhiro Sugimura) .
OT company with their corporate mission, 'Contribution to the health of world people and improvement of the quality of life by Organ Regenerative Medicine and the wellness innovation of the model in the 21st century' have been proceeding operation energetically in a field of Regenerative Medicine, life health care and the medical health care. OT company, features in three technical categories, hair reproduction technology, dentistry reproduction technology and artificial skin technology. Especially for the hair regenerative medicine, OT company has advanced to the stage of the non-clinical tests, and they push forward a plan for realization of the organ regenerative medicine from Japan steadily at first in the world. This investment is allotted to the funds for research and development of the OT company including the development for the offer of the hair regenerative medicine.
ITOCHU has positioned the pharmaceutical and health care markets as a priority area and is actively developing related businesses not only in Japan, but in China and other parts of Asia where we excel. Through the capital and business alliance established this time, ITOCHU will support the expansion of OT company's business in regenerative medicine. In addition, ITOCHU will continue to respond to the demand for uninsured medical care such as hair regeneration associated with the rise in health and beauty consciousness in Japan, and will also develop businesses in China, other parts of Asia, and North America using its overseas networks.
By effectively harnessing the expertise it has developed in pharmaceutical-related businesses, ITOCHU will accelerate the growth of businesses in advanced technologies and services in the fields of cell therapy and new drug development and introduce those businesses to the world.
Overview of Organ Technologies Inc. (as of June 20, 2018)
Company Name
Organ Technologies Inc.
President
Yasuhiro Sugimura
Address
5F Toto Building, 5-1-4, Toranomon, Minato-ku, Tokyo
Number of Employees
11
Company Website
http://www.organ-technol.co.jp/
Business
Manufacturer of hair reproduction technology,
dentistry reproduction technology
and artificial skin technology using regenerative medicine technology
Precise manipulation for technical development of regenerative medicine
Laboratory for advanced researches
Attachments
Original document
Permalink
Disclaimer
Itochu Corporation published this content on 20 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 June 2018 04:12:08 UTC
Itochu Corporation is a diversified group organized around 8 areas of activity:
- distribution of food products (34.9% of net sales): frozen food, vegetable oil, sweeteners, sugars, etc.;
- distribution of hydrocarbons (23.3%): hydrocarbons (natural gas, oil products, bioethanol, etc.). The group also develops manufacturing of chemical products activity;
- manufacturing and sale of industrial and construction machines, vehicles and ships (9.7%);
- production of metals and coal (8.5%);
- sale of consumer products (8.4%). The group also develops forest products sale and real estate development activities;
- distribution of computing and telecommunication equipments (7%): data transmission, Internet access, media content broadcasting and mobile telephony equipments. The group also offers financial services;
- sale of textile products (3.6%);
- other (4.6%).
Net sales are distributed geographically as follows: Japan (79.5%), Singapore (5.4%), the United States (4.5%), Australia (3.1%), China (2.8%) and other (4.7%).
ITOCHU CORPORATION 
